US 7893033
Targeting proteins to deliver therapeutic or diagnostic reagents
granted A61KA61K38/00A61K47/66
Quick answer
US patent 7893033 (Targeting proteins to deliver therapeutic or diagnostic reagents) held by The Board of Regents of the University of Texas System expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00, A61K47/66, A61P, A61P35/00